Unlike classic psychedelics, MDMA works by flooding the brain with positive neurotransmitters. This creates a state of psychological "permissiveness," allowing an individual to approach and re-examine traumatic memories from a new perspective, free from the typical fear response.

Moving beyond Freudian theory and the "chemical imbalance" hypothesis, "Psychiatry 3.0" views mental illness as a problem of brain circuitry. Treatments like TMS and psychedelics show that recalibrating these circuits can rapidly resolve symptoms, framing conditions like depression as correctable rather than a permanent deficit.

Psychedelics disrupt normal brain patterns, which can be powerful for breaking out of neurobiological ruts in middle age. However, using them during the already chaotic and plastic period of brain development in one's 20s may be unnecessarily risky before the brain is 'fully cooked.'

Bryan Johnson explains that as we age, the brain's default mode network (the engine of self and ego) develops stiff, repetitive patterns, narrowing our experience of reality. Psychedelics, especially 5-MeO-DMT, work by powerfully dissolving or 'blasting clean' this network, restoring a more childlike, neuroplastic state.

Psychedelics may treat trauma by reducing activity in the brain's outer cortex (responsible for language, planning). This shifts consciousness to deeper regions like the insular cortex, allowing for profound insights and self-compassion without the usual cognitive filters of guilt and blame.

Psychedelics don't erase traumatic memories. Their therapeutic power comes from inducing a massive perspective shift, allowing the individual to view the same event through a completely new and less threatening lens. This insight suggests most psychological suffering is a perspective problem.

The "filter thesis" suggests the brain doesn't generate consciousness but acts as a reducing valve for a broader reality. This explains why psychedelics, trauma, or near-death experiences—states of disrupted brain activity—can lead to heightened consciousness. The filter is weakened, allowing more of reality to pour in.

fMRI studies on meditators at his events reveal they can dial down the brain's "default mode network"—its predictor based on the past—to a degree previously only seen in people on psilocybin, freeing up immense energy for creation.

Current mental health drugs force a choice: slow-acting daily pills or rapid-acting treatments like Spravato that require frequent, life-disrupting clinic visits. Psychedelic therapies offer a new paradigm by combining rapid onset of efficacy with durability lasting weeks or months from a single dose.